The BMT Data Book: Including Cellular Therapy

— —

Reinhold Munker (Louisiana State University, Shreveport) Gerhard C. Hildebrandt (University of Utah)

The BMT Data Book

Including Cellular Therapy

Reinhold Munker (Louisiana State University, Shreveport), Gerhard C. Hildebrandt (University of Utah), Hillard M. Lazarus , Kerry Atkinson (University of Queensland)

$174.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Cambridge University Press
21 February 2013

Medical ethics & professional conduct; Cytology; Histology; Transplant surgery; Orthopaedics & fractures

This is an essential guide to the data, basic science, outcome studies and decision-making processes involved in blood and marrow stem cell transplantation. Organized according to disease types and procedures, it contains more than 100 tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between different types of chemotherapy, autologous vs. allogeneic transplantation, peripheral blood vs. bone marrow stem cells, and standard vs. experimental treatments. This new edition summarizes the research of the last four years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndrome and Hodgkin and non-Hodgkin lymphomas. New chapters discuss global trends in stem cell transplantation, cellular therapies including donor lymphocytes, and pediatric neurologic and metabolic disorders. With an expanded complications section, links to electronic databases and discussion of new drugs and alternative stem cell sources, this text belongs in every transplant unit.

Edited by: Reinhold Munker (Louisiana State University Shreveport), Gerhard C. Hildebrandt (University of Utah), Hillard M. Lazarus, Kerry Atkinson (University of Queensland)
Imprint: Cambridge University Press
Country of Publication: United Kingdom
Edition: 3rd Revised edition
Dimensions: Height: 234mm, Width: 156mm, Spine: 24mm
Weight: 920g
ISBN: 9781107617551
ISBN 10: 1107617553
Pages: 555
Publication Date: 21 February 2013
Audience: Professional and scholarly , Professional and scholarly , Undergraduate , Undergraduate
Format: Paperback
Publisher's Status: Active

Reinhold Munker, MD is Associate Professor of Medicine, Department of Medicine, Division of Hematology-Oncology, Louisiana State University, Shreveport, LA, USA. Gerhard C. Hildebrandt, MD is Associate Professor of Medicine, Department of Medicine, Division of Hematology-Oncology, Louisiana State University, Shreveport, LA, USA. Hillard M. Lazarus, MD is a Disease Team Leader, Division of Hematology-Oncology, University Hospitals Case Medical Center, Cleveland, OH, USA. Kerry Atkinson, MD, FRCP, FRACP is Professor of Medicine, Division of Hematology-Oncology, University of Queensland, and Head, Stem Cell Biology, Regenerative Medicine and Novel Therapeutic Anti-Cancer Agents Group, Mater Medical Research Institute, Queensland, Australia.

Reviews for The BMT Data Book: Including Cellular Therapy

To maintain high standards of universal care with minimal complications, clinicians need to have the latest and most accurate data source for established indications. The current edition of this book succeeds in fulfilling this requirement [the authors] have excelled in completely updating and timely incorporating the most recent research data available on the subject. Oncology News